NF-κB determines Paneth versus goblet cell fate decision in the small intestine by Brischetto, C. et al.
SUPPLEMENTARY METHODS 
In situ hybridization probes 
In situ hybridization was carried out using the following mouse cDNA probe templates: Axin2 
(nt 282 – 918 of Axin2 cDNA; BC057338) kindly provided by J. Huelsken, ISREC, Lausanne, 
Switzerland/W. Birchmeier, MDC, Berlin, Germany. Cryptidin-1 (nt 3 – 401 of 
NM_010031/AA871421.1; I.M.A.G.E. ID 1096215), kindly provided by M. van de Wetering/H. 
Clevers, Hubrecht Institute, Utrecht Netherlands. Murine Nfkbia (IB; nt 1 – 1091; 
U36277/NM010907). Olfm4 (NM_001030294), kindly provided by J. Heuberger/W. Birchmeier, 
MDC, Berlin, Germany. pBSK-Sox9 (first 1800bp of Sox9 cDNA), kindly provided by T. 
Willnow, MDC, Berlin, Germany. NM_011448). Wnt10a (nt 1295 - 2487, U61969), kindly 
provided by G. Shackleford, UCLA, USA).  
Primers used for quantitative RT-PCR 
Primer name Sequence Origin 
mLysozyme forward: 5'-GCAGCCATACAATGTGCAAAGAGG-3' reverse: 5'-TTTGCCCTGTTTCTGCTGAAGTCC-3' 
(Heuberger et al. 
2014) 
mCryptdin-1 forward: 5'-AGG AGC AGC CAG GAG AAG-3' reverse: 5'-ATG TTC AGC GAC AGC AGA G-3' 
(Tsai et al. 
2014) 
mMath1 forward: 5'-GTTGCGCTCACTCACAAATAAGGG-3' reverse: 5'-TGGCAGTTGAGTTTCTTCAAGGCG-3' 
(Heuberger et al. 
2014) 
mDll4 forward: 5'-TTA CTG CAG CAA GCC AGA TG-3' reverse: 5'-CAT TCT TGC ACG GAG AGT GG-3' 
(Heuberger et al. 
2014) 
mAscl2 forward: 5'-AAAGCTTGGTCCGGTTCTTCATCC-3' reverse: 5'-GCAGATGCTTAGCTTATTGCGTCC-3' 
(Heuberger et al. 
2014) 
mLgr5 forward: 5'-CCTACTCGAAGACTTACCCAGT-3' reverse: 5'-GCATTGGGGTGAATGATAGCA-3' 
(Heuberger et al. 
2014) 
mOlfm4 forward: 5'-CAAGCCTGGCTCGACGGCC-3' reverse: 5'-CGCGAACATCTTCAGGTTCT-3' 
(Heuberger et al. 
2014) 
mSpedf1 forward: 5'-AACATGTATCCCGACGATAGCAGC-3' reverse: 5'-TCAATATCTTTCAGGACCTCGCCC-3' 
(Heuberger et al. 
2014) 
mGob5 forward: 5'-TGAAATTGTGCTGCTGACCGATGG-3' reverse: 5'-TGCTGCGAAAGCATCAACAAGACC-3' 
(Heuberger et al. 
2014) 





















mKlf4 forward: 5'-GAGTTCCTCACGCCAACG-3' 
reverse: 5'-CGGGAAGGGAGAAGACACT-3' 
(Al Alam et al. 
2015) 
mMuc2 forward: 5'-TGTGATGCCAATGACAAGGTGTCC-3' 
reverse: 5'-ACCACAATGTTGATGCCAGACTCG-3' 
(Heuberger et al. 
2014) 
mAxin2 forward: 5’-ACTGACCGACGATTCCATGT-3’ 
reverse: 5’-CTGCGATGCATCTCTCTCTG-3’ 
NM_015732.4 
mSST forward: 5’-ACCGGGAAACAGGAACTGG-3’ 
reverse: 5’-TTGCTGGTTCGAGTTGGC-3’ 
(Mustata et al. 
2011) 
mChromoA forward: 5’-TCCCCACTGCAGCATCCAGTTC-3’ 
reverse: 5’-CCTTCAGACGGCAGAGCTTCGG-3’ 
(Mustata et al. 
2011) 
mDll1 forward: 5’-CCGATGACCTCGCAACAGAA-3’  
reverse: 5’-CCAGGGTCGCACATCTTCTC-3’ 
(Zhang et al. 
2019) 
mHes1 forward: 5’-GGAGAAGAGGCGAAGGGCAAGA-3’ 
reverse: 5’CGT GGACAGGAAGCGGGTCA-3’ 
(Zhang et al. 
2019) 
mGfi1 forward: 5’-TCCACACTGTCCACACACCT-3´ 
reverse: 5´-CTGGCACTTGTGAGGCTTCT-3´ 
(Zhang et al. 
2019) 
mWnt3a forward: 5’-TGGAACTGTACCACCATAGATGAC-3’ 
reverse: 5’-ACACCAGCCGAGAGCGATG-3’ 
(Farin et al. 
2012) 
mWnt10a forward: 5’-GAGAGCCTCACAGAGACATCCAT-3’ 
reverse: 5’-TACTGTGCGGAACTCAGGCGT-3’ 
NM_009518 
mSox9 forward: 5’-GACTCCCCACATTCCTC-3’ 
reverse: 5’-CCTCTCGCTTCAGATCAAC-3’ 
NM_011448 
mCtnnb1 forward: 5’-TGCCATCTGTGCTCTTCGTC-3’ 
reverse: 5’-AACTGCTGCTGCGTTCCAC-3’ 
NM_007614 
mIcam1 forward: 5’-CTGCGTTTTGGAGCTAGCGG-3’ 
reverse: 5’-TTGGCTCCCTTCCGAGACCT-3’ 
NM_010493 
mTNF forward: 5’-TCCCAAATGGCCTCCCTCTCC-3’ 
reverse: 5’-CCACTTGGTGGTTTGCTACGA-3’ 
NM_013693 
mIL6 forward: 5’-ACAAAGCCAGAGTCCTTCAGAGA-3’ 
reverse: 5’-AGCCACTCCTTCTGTGACTCC-3’ 
NM_031168 
mIL1α forward: 5’-GGAGAGCCGGGTGACAGTATC-3’ 
reverse: 5’-TCTGGGTTGGATGGTCTCTTC-3’ 
NM_010554.4 
mGAPDH forward: 5'-AGCAAGGACACTGAGCAAGAG-3' 
reverse: 5'-GCAGCGAACTTTATTGATGGT-3' 
NM_008084 
mHprt forward: 5’-GGATATGCCCTTGACTATAATGAG-3’ 
reverse: 5’- GGCAACATCAACAGGACTC-3’ 
NM_013556 
mNfkbia forward: 5’-AGGAGTACGAGCAAATGG-3’ 
reverse: 5’-CAGGCAAGATGTAGAGGG-3’ 
NM_010907 
mCXCL12 forward: 5’-TCTTCGAGAGCCACATCGCC-3’ 
reverse: 5’-AGCCGTGCAACAATCTGAAGG-3’ 
NM_021704.3 
mLcn2 forward: 5´-ACTTCCGGAGCGATCAGTTC-3´ 
reverse: 5´-TTTTTCTGGACCGCATTGCC-3´ 
NM_008491.1 
mNos2 forward: 5´- TTTCACCCGCTTTGCCAAGT-3´ 
reverse: 5´- GTCTCTGCGCATCCCAGTCA-3´ 
NM_001313921.1 





















mNox1 forward: 5´- CTCCAGCCTATCTCATCCTGAG-3´ 
reverse: 5´- AGTGGCAATCACTCCAGTAAGGC-3´ 
NM_172203.2 
mTNFIP3 forward: 5´- GTCAGGAAGCTCGTGGCTCT-3´ 
reverse: 5´- TTAAGGGTGCTGCAGAGGGC-3´ 
NM_001166402.1 
mLbp forward: 5´- TGCTGTTTGCTGCAGACAAC-3´ 
reverse: 5´- TGGGTCCAACCAAAACCTTC-3´ 
NM_008489.2 
mSmoc2 forward: 5´ AGCTGGGGCAATTCTTTCAG-3´ 
reverse: 5´- AATGAGCAAAGGCCTTCTGC-3´ 
NM_022315.2 
mLgr1 forward: 5´- ATTTGATGGTCTGTCGCGGT-3´ 
reverse: 5´- GTGCAGCACGTGCATCTTAG-3´ 
(Heuberger et al. 
2014) 
mTert forward: 5´-AGAAACGTGCTGGCTTTTGG-3´ 
reverse: 5´- AACAGTGTTGGGCAAGTAGC-3´ 
NM_009354.2 
mHopx forward: 5´- AGTTCCTTCCCTTACAGCTGTG-3´ 
reverse: 5´-ACTTGCTTTTCTGCCCCTTG-3´ 
NM_001159900.1 
mCcdn1 forward: 5´- AGTTCATTTCCAACCCACCC-3´ 
reverse: 5´- AGACCAGCCTCTTCCTCCAC-3´ 
NM_001379248.1 
mEdn1 forward: 5´- ACTACGAAGGTTGGAGGCCA-3´ 
reverse: 5´- CAATGTGCTCGGTTGTGCGT-3´ 
NM_010104.4 
mProm1 forward: 5´- CTGAAGATTGCCCTCTATGA-3´ 
reverse: 5´- AGTTTCTGGGTCCCTTTGAT-3´ 
NM_001163577.1 
mEphb3 forward: 5´- GACCTTGCTGCCCGAAACAT-3´ 
reverse:5´- CCCACATGACAATCCCATAGCT-3´ 
NM_010143.1 
mMsi1 forward: 5´- AAAACCACCAACAGGCACAG-3´ 
reverse: 5´- TGGGCTTTCTTGCATTCCAC-3´ 
NM_001376960.1 
mTnfrsf19 forward: 5´- TGAAAGTGGCGGTGAATGTG-3´ 
reverse: 5´- AACATTCACAGCCAGGCTTC-3´ 
NM_001164155.1 
Antibodies  
- Non-phospho (active) -Catenin (Ser33/37/Thr41), rabbit, Cell Signaling (#8814), 1:500  
- BrdU, mouse, Sigma (BU33), 1:500 
- Chromogranin A, rabbit, Abcam (15160), 1:300 
- Cleaved Caspase-3 (Asp175), rabbit, Cell Signaling (9664), 1:400 
- Digoxigenin-AP Fab fragments, sheep, Roche (11093274910), 1:1000 
- E-Cadherin, mouse, BD (610181), 1:500 
- EGFP, chicken, Abcam (ab13970), 1:400 
- Ki67, rabbit, Abcam (ab15580), 1:100 





















- Ldha (Lactate dehydrogenase A), Santa Cruz (sc-27230), 1:1000 
- Lysozyme, rabbit, DAKO (A 0099), 1:1000 
- Mmp7 (matrix metalloproteinase-7), Santa Cruz sc-515703, 1:1000 
- Muc2 (Mucin 2), rabbit, Santa Cruz (sc-15334), 1:100 
- Olfm4, rabbit, Cell signaling (D6Y5A), 1:400 
- Parp1 (Poly(ADP-ribose)-polymerase 1), mouse, Santa Cruz (sc-8007), 1:1000 
- Sox9 (SRY-box 9), rabbit, Santa Cruz (sc-20095) 1:100, (Vidal et al. 2005; Nowak et al. 
2008), and rabbit, Millipore (AB5535), 1:200. 






































































Fig. S1. (A) NF-κB activity is suppressed in SI crypts of ∆N mice. In situ hybridization on PSI sections of control and ∆N mice 
using a riboprobe for mouse Nfkbia (NF-κB inhibitor IκBα, bona fide target gene of NF-κB). Arrowheads point to Nfkbia mRNA 
expression. Scale bars = 50µm. Note that in ∆N mice a C-terminal deletion mutant of the human IκBα was used which is not detected 
by the murine Nfkbia riboprobe (see (Schmidt-Ullrich et al. 2001; Schmidt-Ullrich et al. 2006)). (B – C) β-catenin protein expression 
is maintained in ∆N and loxP-∆N mice. (B) PSI whole cell protein extracts of control, ∆N and loxP-∆N mice (n=3/group n1 or 
n2) were used for SDS-PAGE Western blotting with an antibody against nuclear β-catenin. β-actin was used as loading control. 
(C) Quantification of nuclear β-catenin protein expression normalized to β-actin (from (B)). n.s.= not significant, p=0.658 (one-
way Anova), error bars = SEM. Note that ∆N and loxP-∆N mice maintain levels of nuclear β-catenin protein expression that are 
identical to controls, in spite of one-allelic expression from Ctnnb1 gene (see (Schmidt-Ullrich et al. 2001)). (D - E) No increase in 
inflammatory cytokines in small intestines of ∆N mice. (D) Quantitative real-time PCR (qRT–PCR) for inflammatory cytokines 
(Cxcl12, Icam, Il6, Tnfa, and Il1a) using RNA from PSIs of ∆N and control mice (n=3/group). Observed differences were statistically 
insignificant. Error bars = SEM. (E) qRT–PCR for inflammatory cytokines (Il6, Il1a, Tnfa, Icam1, Cxcl12) using RNA from bulk 
organoids from IκBαIEC-KO mice (n=4; constitutively increased NF-κB activity in the SI epithelium; used as positive control for (D)). 
mRNA expression was normalized to 2 reference genes, Hprt1 and Sdha (Succinate dehydrogenase complex, subunit A). Expression 
of control animals (n=4) was normalized to 1. Mean ratio of IκBαIEC-KO to control is shown. **: p<0.01, error bars = SEM. (F) 
Quantitative real-time PCR (qRT–PCR) for NF-κB target genes that are known to be upregulated in inflammatory bowel disease 
(IBD; see (Mikuda et al. 2020)). Left panel: Nos2  (Nitric Oxide Synthase), Nox1 (NADPH Oxidase 1), Tnfaip3 (A20; Tumor Necrosis 
Factor alpha-induced protein 3), Lbp (Lipopolysaccharide Binding Protein). Right panel: Lcn2 (NGAL, Lipocalin 2). RNA from PSIs 
of ∆N, IκB αIEC-KO and control mice (n=3/group) was used. Expression of control animals was normalized to 1. ***: p<0.001, ****: 
p<0.0001, error bars = SEM. 
































Fig. S2. (A) No increased apoptosis in SI epithelium of ∆N mice. IF TUNEL staining on PSI sections of ΔN mice and controls (n=4/
group). Green arrows point to TUNEL-positive cells. Nuclear counterstaining: DAPI. Scale bars = 50 μm. (B) Increased numbers of 
Alcian blue-positive (goblet) cells also in the jejunum and ileum of ∆N mice. Sections of middle (MSI, jejunum) and distal (DSI, 
ileum) SI of control, ∆N and Villin-∆N mice (n=3/group) stained either with Alcian Blue (blue) alone or together with an anti-
Lysozyme antibody (brown; DAB). Scale bars = 50µm.  









































































Fig. S3. Reduced numbers of Paneth cells also in the jejunum and ileum of ∆N mice. (A) Anti-Lysozyme 
antibody staining (green) on sections of middle (MSI, jejunum) and distal (DSI, ileum) SI of control, ∆N and 
Villin-∆N mice (n=3/group). White arrows indicate remaining Paneth cells in ∆N and Villin-∆N crypts. Scale bars 
= 50µm. (B – D) Paneth cell loss in ∆N mice was further verified by strongly reduced Cryptdin-1 and MMP7 
expression. (B) In situ hybridization using a riboprobe for Cryptdin-1 on PSI sections of control, ∆N and Villin-∆
N mice (n=3/group). Black arrows indicate remaining Paneth cells in PSI crypts of ∆N and Villin-∆N mice. Due 
to one Paneth cell/crypt at most, Cryptdin-1 expression is strongly reduced in ∆N and Villin-∆N crypts when 
compared to controls (see insets). Scale bars = 50µm. (C) Anti-Mmp7 antibody staining on PSI sections of control 
and ∆N mice (n=3/group). White arrows indicate remaining Paneth cells in ∆N mice which express Mmp7. 
Original magnification 200x. (D) Comparing protein expression of Mmp7 in ∆N and control mice (n=3/group).  PSI 
whole cell extracts of control and ∆N mice were used for SDS-PAGE Western blotting. 































































































Fig. S4. (A) NF-κB remains active in the absence of goblet and Paneth cell maturation factor Spdef1.  
(A) IHC using anti-EGFP antibody on PSI sections of Spdef-/- ;κ-EGFP (Spdef KO) and Spdef+/+;κ-EGFP 
(controls) mice (n=3/group). Scale bars = 50μm and 10µm (right panels). White asterisk indicates background 
staining. (B – D) NF-κB activity is required for postnatal Paneth cell differentiation. (B) Anti-EGFP (red) and 
-Lysozyme (green) antibody staining on PSI sections of κ-EGFP mice at P9, P15 and 8 weeks of age (n=3/group).  
Nuclear counterstain: DAPI (blue). NF-κB activity is already detected in 
Paneth cell precursors at P9. Yellow arrows point to Paneth cells with active NF-κB (P9 and P15). Scale bars 
upper panels = 50µm, lower panels = 20µm. (C) IHC on PSI sections of control and ∆N mice (n=3/group) 
stained with Alcian Blue and with anti-Lysozyme antibody (brown; DAB). While in controls the number 
of Paneth cells/crypt increases between P15 and 8 weeks of age, this is not the case in ∆N mice. Scale bars 
= 20µm. (D) Transmission electron microscopy of PSI crypts of ∆N and control mice: Quantification of 
crypts containing Paneth cells in ∆N mice compared to controls (n=4/group) confirms data shown in Fig. 2. 
****: p<0.0001, error bars = SEM.  





























































Fig. S5. (A, B) Unaltered numbers of enteroendocrine cells in ∆N mice. (A) IHC using an anti-
Chromogranin-A antibody on PSI sections of control and ∆N mice (n=3/group). Arrows 
point to enteroendocrine cells. Scale bars = 50µm. (B) qRT–PCR for enteroendocrine markers 
Chromogranin-A (ChromoA) and Somatostatin (SST) using RNA isolated from PSIs of ∆N and control mice 
(n=3/group). Error bars = SEM. (C – H) Altered expression of Wnt-dependent ISC markers in ∆N 
mice. (C) In situ hybridization for ISC marker Olfm4 on PSI (proximal small intestine; duodenum) 
sections of ∆N and control mice (n=3/group). (D, E) qRT–PCR for Wnt-independent (D) and -
dependent (E) ISC markers (see (Mikuda et al. 2020)), using 
RNA from PSIs of control and ∆N mice (n=3/group). Lgr1: Leucine-rich repeat-containing G-protein 
coupled receptor 1; Smoc2:  SPARC-related modular calcium-binding protein 2; Tert: Telomerase reverse 
transcriptase; Hopx: Homeodomain-only protein homeobox; Olfm4: Olfactomedin 4; Ccnd1: Cyclin D1; 
Edn1: Endothelin 1; Ephb3: Ephrin type-B receptor 3; Msi1: Musashi RNA-binding protein 1; Prom1: 
Prominin 1;  Tnfrsf19: Troy, TNF receptor superfamily member 19; Lgr5: Leucine-rich repeat-containing 
G-protein coupled receptor 5; Ascl2: Achaete scute-like 2; n.s. = not significant, *: p<0.05, **: p<0.01; 
error bars = SEM. (F) IF using an anti-EGFP (green) antibody on PSI sections of Lgr5-EGFP and 
Lgr5-EGFP;∆N mice (n=3/group). Nuclear counterstain: DAPI (blue). Green arrowheads point to 
scarce Lgr5 expression in crypts of ∆N mice. Scale bar = 100µm. (G) Quantification (in %) of EGFP-
positive (Lgr5-expressing) cells in ∆N compared to control mice (n=5/group) by FACS. *: 
p<0.05; error bars = SEM.  (H) Quantification (in %) of Ki67- versus Lgr5-positive cells in PSI of 
Lgr5-EGFP and Lgr5-EGFP;∆N mice (n=3/group). *: p<0.05; error bars = SEM. 









































































Fig. S6. Wnt rescues organoid growth in ∆N mice. (A) Single, EGFP-positive cells isolated from Lgr5-
EGFP (control) or Lgr5-EGFP;∆N mice (∆N) by FACS and cultured in presence (WENR) or absence of 
Wnt (ENR). n=3 independent experiments; d0 – d6 = days of culture. (B) EdU incorporation together with 
anti-Lysozyme or anti-Muc2 (both green) staining in control and ∆N organoids (from 3 mice/group) at 
culture day 7 (d7) in WENR medium, verified by EdU antibody staining (purple). Nuclear counterstain: 
DAPI (blue). (C, D) Representative qRT–PCR for stem cell markers Lgr5 and Ascl2 using RNA isolated from
bulk organoids grown either in ENR or WENR medium. **: p<0.01, ****: p<0.0001; error bars = SEM. (E) 
Representative image of NF-Βκ activity in Paneth cells of crypt organoids: Anti-EGFP and -Lysozyme antibody 
staining on cultured organoids obtained from κ-EGFP mice (n=3). Yellow arrowheads point to Paneth cells. 
Scale bar = 20µm. (F) Quantification (in %) of Ki67-positive cells of bulk control and ∆N organoids grown 
either in ENR or WENR medium. Two-way ANOVA with Bonferroni´s multiple comparison test, 
****p<0.0001, n.s. = not significant; error bars = SEM.     








































































Fig. S7.  (A, B) Overall Wnt/β-Catenin activity appears to be maintained in crypts of ∆N mice 
(A) Cryosections  
of whole mount X-Gal-stained (blue) PSIs obtained from WNT reporter cond-lacZ (controls) and cond-lacZ;∆N mic
e  (n=3/group). Black arrows point to β-galactosidase expression (= Wnt activity) in transit amplifying (TA) cells in  
controls (upper panels) and in the bottom of ∆N-positive crypts (lower panels). Red arrow points to CBC stem cells.  
Scale bars = 30µm. (B) Left panels: In situ hybridization for canonical Wnt/β-Catenin target gene Axin2 on PSI  
sections of control and ∆N mice (n=3/group). Insets: Asterisks in controls indicate Paneth cells. Black arrows point t
o  Axin2 in TA cells of controls and to aberrant Axin2 mRNA expression in ∆N-positive crypt bottoms. Scale bars =  
50µm. Right panel: qRT–PCR for Axin2 using RNA from PSIs of ∆N and control mice (n=3/group), normalized to  
1 (control). n.s., not significant. (C) Quantification of Sox9 protein in ∆N-positive SI epithelium compared to  
controls. Upper panel: SDS-PAGE Western blotting using PSI whole cell extracts from control and ∆N mice 
(n=3/group) showing Sox9 protein expression. Lower panel: Quantification of Sox9 protein expression normalized t
o vinculin. *: p<0.05, error bars = SEM. (D - I) Sox9 protein is co-expressed with EGFP (equivalent to active nu
clear NF-κB in the cell). IF using anti-EGFP and Sox9 antibody co-staining on sections of PSI of κκ
−EGFP reporter mice (n=3/group). Yellow arrow heads point to 
cellular co-localization of Sox9 expression and NF-κB activity (EGFP expression). Nuclear counterstain: DAPI.  
Scale bars = 10µm. 
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